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ARTICLE
Ribosomal mistranslation leads to silencing
of the unfolded protein response and increased
mitochondrial biogenesis
Dmitri Shcherbakov1,4, Youjin Teo1,4, Heithem Boukari1, Adrian Cortes-Sanchon1, Matilde Mantovani1,
Ivan Osinnii1, James Moore1, Reda Juskeviciene1, Margarita Brilkova1, Stefan Duscha1,
Harshitha Santhosh Kumar1, Endre Laczko 2, Hubert Rehrauer 2, Eric Westhof3, Rashid Akbergenov1,4 &
Erik C. Böttger 1*
Translation ﬁdelity is the limiting factor in the accuracy of gene expression. With an esti-
mated frequency of 10−4, errors in mRNA decoding occur in a mostly stochastic manner.
Little is known about the response of higher eukaryotes to chronic loss of ribosomal accuracy
as per an increase in the random error rate of mRNA decoding. Here, we present a global and
comprehensive picture of the cellular changes in response to translational accuracy in
mammalian ribosomes impaired by genetic manipulation. In addition to affecting established
protein quality control pathways, such as elevated transcript levels for cytosolic chaperones,
activation of the ubiquitin-proteasome system, and translational slowdown, ribosomal mis-
translation led to unexpected responses. In particular, we observed increased mitochondrial
biogenesis associated with import of misfolded proteins into the mitochondria and silencing
of the unfolded protein response in the endoplasmic reticulum.
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The accuracy of gene expression is central to the ability ofliving organisms to efﬁciently translate genomic informa-tion into functional proteins. Errors in DNA replication
occur in a frequency of ~10–8, and the error rate in mRNA
transcription is in the rage of ~10–6 1. By comparison, the average
error rate in mRNA decoding by the ribosome has been estimated
to be in the order of 10–4, making it the limiting factor in the
accuracy of gene expression2,3.
Errors in mRNA decoding by prokaryotic or eukaryotic ribo-
somes mostly result in missense substitutions as per incorpora-
tion of mismatched tRNAs4. Due to the physical constraints of
the mRNA-tRNA interaction, accommodation of mismatched
tRNAs is limited to near-cognate tRNAs, leading mostly to
missense amino acid substitutions that are conservative in nature
because of the way the genetic code is arranged5,6. Missense
errors are in part codon-dependent and affected by the levels of
tRNA aminoacylation3,7,8.
Classical ribosomal ambiguity mutations (ram) in bacteria or
yeast are generalized misreaders resulting in increased missense,
read-through, and nonsense errors4. Mechanistically, ram muta-
tions increase the physiological error rate of translation in a
random and stochastic manner by affecting the initial phase of
tRNA selection resulting in reduced discrimination against near-
cognate tRNAs9,10. In higher eukaryotes reported defects in
translational accuracy have mostly been linked to mutations
which affect ribosomal accuracy in a non-random manner, i.e.,
mutations in speciﬁc aminoacyl-tRNA synthetases. Typically,
these mutations come along with severe disease pathologies11–15.
Protein misfolding is a common outcome of ribosomal mis-
translation and cells have developed multiple means to monitor
and remove mistranslated proteins in a process collectively
known as proteostasis, an interconnected network comprising
more than 1000 known components in the mammalian system.
Under normal conditions, molecular chaperones aid and monitor
protein folding in a spatial and timely manner16. When the
balance of protein homeostasis is disrupted, transcriptional pro-
grams dedicated to speciﬁc cellular compartments such as the
cytosolic stress response and the unfolded protein response
(UPR) pathways are activated in addition to the ubiquitin-
proteasome pathway and autophagy to aid refolding of misfolded
proteins and to remove terminally misfolded and aggregated
proteins17–19.
Increases in the random error rate of protein synthesis have
rarely been studied in higher eukaryotes. To ﬁll this gap, we
wished to establish a corresponding genetic model and to study
the cellular responses by proﬁling the global transcriptomic and
metabolomic changes together with experimental validation and
functional studies. We show that mistranslation results in a
proteostatic response that attenuated cytosolic protein synthesis
and the cell cycle, together with increased expression of cytosolic
chaperones and activation of the ubiquitin-proteasome system. In
addition, ribosomal mistranslation limits protein import into the
endoplasmic reticulum and silences the unfoled protein response
(UPRER) to circumvent UPRER-triggered apoptotic pathways,
and leads to increased mitochondrial biogenesis associated with
import of misfolded proteins into the mitochondria.
Results
Identiﬁcation of a ram mutation in higher eukaryotes. Muta-
tion RPS2 S200Y in the lower eukaryote Saccharomyces cerevisiae
(uS5) is a well-known ribosomal ambiguity mutation (ram) that
disrupts the RPS2(uS5)-RPS9 (uS4) interface on the small ribo-
somal subunit (Supplementary Fig. 1)20–22. By aligning the RPS2
(uS5) sequences of S. cerevisiae and Homo sapiens, we identiﬁed
A226Y as the homologous human RPS2 mutation, corresponding
to RPS2-S200Y in yeast. Structural modeling of the human RPS2
(uS5)-RPS9(uS4) interface suggested that the RPS2-A226Y
mutation would result in steric hindrance between the tyrosine
residue and the α-helix in the protein C-terminal domain,
affecting the conformation of RPS2 and thus its interaction with
RPS9 (Supplementary Fig. 1e, f). Based on the modeling results,
we hypothesized that RPS2 A226Y would confer mistranslation in
higher eukaryotes.
To assess whether the identiﬁed mutation confers mistranslation
in human ribosomes, we generated stable transfected HEK293 cells
constitutively expressing wild-type RPS2 or mutant RPS2-A226Y
resulting in cells termed wild-type (cells transfected with RPS2-wt)
and A226Y (cells transfected with RPS2-A226Y), respectively,
untransfected HEK293 cells were termed HEK293 cells; this
nomenclature is used throughout the paper. Transfection with
myc-tagged wild-type RPS2 and mutant A226Y RPS2 genes showed
that the myc-tagged RPS2 was enriched in the ribosomal fraction,
indicating that the transgenic RPS2 protein was being incorporated
into functional ribosomes. Additional experiments demonstrated
that the transfected RPS2 protein is incorporated into actively
translating polysomes (Supplementary Fig. 2a, b).
To assess the expression levels of transgenic versus endogenous
RPS2, we performed Taqman qRT-PCR. mRNA levels for
transfected RPS2-wt ranged between 30–40% of total RPS2
expression. In contrast, RPS2-A226Y transgenic mRNA was
expressed at only ~10% of total RPS2 expression (Fig. 1a). The
reduced expression of the RPS2-A226Y transgene was mirrored
by expression levels of an IRES-GFP-reporter fused downstream
of transgenic RPS2 as an alternative method for transgene
quantiﬁcation (Supplementary Fig. 2c).
The ability of RPS2 mutation A226Y to induce misreading and
stop codon read-through was assessed using the dual-luciferase
mistranslation reporter system as previously described23,24. In
this assay, the active site H245 of ﬁreﬂy luciferase (Fluc) was
mutated from CAC to near-cognate CGC and to non-cognate
AGA, resulting in a non-functional protein. To measure read-
through, stop codon TGA was introduced at D357 of Fluc to
produce a truncated and non-active Fluc. The misreading agent
geneticin was included as a positive control for both assays. In
comparison to RPS2 wt, we found that RPS2-A226Y mutant cells
showed increased levels of near-cognate misreading (2.2-fold)
and stop codon read-through (5.4-fold) (Table 1). The ﬁnding of
RPS2-A226Y-mediated ribosomal misreading provides further
evidence that transfected RPS2 is incorporated into ribosomes
and present in actively translating ribosomes. As previously
reported for ram mutations in E. coli and yeast, RPS2 mutation
A226Y only affected misreading of near-cognate but not of non-
cognate codons (AGA column, Table 1). Further, A226Y-
mediated read-through was found to extend to disease-
associated nonsense codons in the context of Hurler disease
and cystic ﬁbrosis (Table 1).
Together, these data identify the replacement of valine by
tyrosine at RPS2 aa position 226 as a ram mutation and
demonstrate that the transfected RPS2 is incorporated into
actively translating ribosomes.
Effects of RPS2 A226Y on translation. Cell viability was not
measurably affected in the RPS2-A226Y mutants (Fig. 1b),
however, we detected a signiﬁcantly longer generation time
compared to RPS2 wt transfected cells (Fig. 1c). This loss of ﬁt-
ness, a hallmark of ram mutations, was exacerbated by the ami-
noglycoside geneticin (Fig. 1c).
To assess whether A226Y-induced mistranslation resulted in
increased protein aggregation in the cell, we used cells transfected
with a misfolding-prone ﬁreﬂy luciferase reporter25. Using
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antibodies against Fluc, we performed western blots of the soluble
and pellet fractions of cellular extracts. The distribution of Fluc
shifted towards the insoluble pellet fraction for the A226Y
mutants compared to RPS2 wt indicating that the misreading
mutation A226Y induced higher levels of luciferase aggregation
(Fig. 1d, Supplementary Fig. 2d).
Translational activity in the A226Y mutants was substantially
reduced as assessed by in vivo 35S-methionine incorporation
(Fig. 1f). Polysome proﬁling demonstrated that the decrease in
protein synthesis was accompanied by an increase in monosomes
in the A226Y mutants (Fig. 1e). To investigate how translational
activity was regulated, we ﬁrst studied eukaryotic translation
initiation factor 2α (eIF2α) phosphorylation as an indicator of
initiation inhibition26. In contrast to arsenite, a known inducer of
eIF2α phosphorylation, western blotting failed to detect differ-
ences in eIF2α phosphorylation between A226Y and wild-type
cells suggesting that translation was not regulated at the level of
initiation (Fig. 1g).
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Fig. 1 Characterization of RPS2 A226Y mutant cells. a RPS2 transgene expression as a fraction of total RPS2 mRNA expression using TaqMan qRT-PCR
(N≥ 4). HEK293= untransfected HEK cells; WT=HEK cells transfected with wt RPS2; A226Y=HEK cells transfected with RPS2 A226Y. b Trypan blue
exclusion assay for the determination of cell viability (N= 6). Staurosporine (STA, 10 μM, 24 h) used as positive control for cell death. c Generation time
with and without geneticin treatment as determined by Alamar blue assay (4≤ N≤ 6). d Fireﬂy luciferase aggregation assay (N≥ 3). A representative
western blot can be found in Supplementary Fig. 2d. e Polysome proﬁling of HEK293 (non-transfected), RPS2 WT, RPS2 A226Y, and 0.5 mM arsenite-
treated HEK WT cells. The polysome to monosome (P/M) ratios were calculated using the area under the curve of the polysome and the 80 S monosome
peaks. Representative ﬁgures are shown (N= 3). f In vivo protein synthesis determined by radiolabelled methionine (35S-Met) incorporation (N= 3).
g Western blot to determine the phosphorylation status of eIF2α. Antibodies against phosphorylated and unphosphorylated eIF2α were used. Arsenite
(Ars, 0.5 mM, 1 h) used as positive control, GAPDH as loading control (N= 3). h Polysome half-life as derived from the polysome runoff assay (N≥ 4).
Treatment with elongation inhibitor cycloheximide (CHX) used as positive control. See also Supplementary Fig. 2e-g. **p < 0.01, ***p < 0.005. N= number
of independent clones analyzed for each genotype; for each clone 3 technical replicates were done. Mean ± SEM is given
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Next, we used polysome run-off assays to study translation
elongation. The translation inhibitor harringtonine stalls initiat-
ing ribosomes at the start codon while allowing initiated
ribosomes to continue elongating and run off their transcripts.
The time it takes for polysome depletion after harringtonine
treatment correlates with translation elongation speed27 (Supple-
mentary Fig. 2e). Compared to RPS2 wt, A226Y mutants showed
slower polysome runoff, i.e., a reduced elongation rate (Fig. 1h,
Supplementary Fig. 2f). Cycloheximide, a known inhibitor of
translation elongation was included as a positive control for
elongation slowdown (Supplementary Fig. 2g).
Transcriptome proﬁling of A226Y-induced mistranslation. To
examine globally how the mammalian cell responds to chronic
mistranslation, we analyzed the transcriptome response of A226Y
mutants using RNA sequencing (RNA-Seq). 5550 genes were
differentially regulated in the A226Y mutants compared to RPS2
wt (p < 0.05) (Supplementary Fig. 3a, b). Process network and
Gene Ontology (GO) enrichment analyses identiﬁed signiﬁcantly
regulated processes involved in proteolysis, protein folding,
translation, apoptosis, cell cycle regulation and DNA damage
repair (Supplementary Fig. 3c, d). As expected, mistranslation
results in activation of various protein quality control pathways,
as revealed, for example, by elevated transcript levels for cytosolic
chaperones and the ubiquitin-proteasome system. However, two
ﬁndings were unanticipated. First, transcripts for the UPR were
decreased in the A226Y mutants. Second, pathways involved in
mitochondrial translation and protein import were signiﬁcantly
increased in the A226Y mutants (Supplementary Fig. 3d).
Translation and protein quality control pathways. We found
decreased transcript levels of genes involved in cytosolic protein
synthesis, including structural ribosomal proteins, aminoacyl
tRNA synthetases, and elongation factors (Supplementary Fig. 4a,
b), consistent with our experimental data showing reduced
translational activity and elongation slowdown. We also found
increased transcript levels of ribosomal release factors eRF1
and eRF3 (Supplementary Fig. 4b), most likely reﬂecting a
response to A226Y-mediated increased stop codon read-through.
In addition, we observed elevated transcript levels for cytosolic
chaperones and proteasome components (Supplementary Fig. 4c,
d). Thus, A226Y-induced mistranslation upregulates cytosolic
protein quality control pathways. We corroborated these ﬁndings
by western blot analysis to detect ubiquitination at the protein
level and by measuring the proteolytic activity of the 26S
proteasome. The A226Y mutants showed signiﬁcantly increased
levels of ubiquitination and of proteasomal degradation com-
pared to the wild-type (Supplementary Fig. 4e–g). In line with
these observations we found that A226Y-mediated mistranslation
increases susceptibility to proteasomal inhibitors. Treatment with
proteasome inhibitor MG132 resulted in signiﬁcantly increased
cell death in the A226Y mutants as compared to RPS2 wt
(Supplementary Fig. 4h).
KEGG analysis revealed reduced gene transcript levels for
pathways involved in biosynthesis and metabolism of amino acids
(Supplementary Tables 1, 2). In combination with increased
transcript levels of genes involved in proteasome-mediated
proteolysis, this observation suggests an extensive recycling of
amino acids for protein synthesis. To complement our gene
expression data, we assessed the metabolic changes in the A226Y
mutants. Metabolome analysis identiﬁed signiﬁcantly increased
levels of dipeptides (remnants of proteolytic activity), while
metabolites involved in amino acid metabolism and gamma-
glutamate-dependent amino acid import were signiﬁcantly
reduced (Supplementary Fig. 4i, j, Supplementary Tables 1, 2,
3). These ﬁndings corroborate the transcriptome data suggesting
activation of proteasome-mediated proteolysis and increased
recycling of amino acids.
Chronic mistranslation results in G1/S transition defect. Pro-
cess network enrichment analysis revealed an enrichment of cell
cycle networks in the A226Y mutant. In short, we found
increased levels of CDK inhibitors together with decreased
transcript levels for genes involved in mitosis, DNA replication
and repair, all suggestive of a G1/S transition defect in the mutant
(Fig. 2a, b). Compared to the control, A226Y mutants showed a
higher proportion of cells in G1/S (Fig. 2c) when DNA was
stained with propidium iodide. This observation was corrobo-
rated by the higher amounts of Cdk2-pTyr15 protein (G1/S
enriched protein) detected in the A226Y mutants compared to
wild-type cells28 (Fig. 2d).
Chronic mistranslation reduces protein import into ER.
Another ﬁnding from our GO enrichment analysis was the
decreased transcript levels for the ER protein targeting machinery
(Supplementary Fig. 3d). Protein transport into the ER happens
via three routes: the signal recognition particle-dependent (SRP)
pathway, the SRP-independent pathway, and guided entry of tail-
anchored protein (GET)29,30. Global transcriptome proﬁling
suggested that the components directly involved in translocation
across the ER membrane for all three routes were reduced in the
A226Y mutant. This is indicated by signiﬁcantly reduced tran-
script levels of genes encoding for the main players involved:
SERP1, SPase, SSRs, SEC63, and CAMLG, with the marked
exception of SEC61, possibly due to its suggested role in ER
dislocation, i.e., the export of misfolded proteins back to the
cytosol for proteolytic degradation31 (Fig. 2e). To challenge this
ﬁnding, we used a Fluc reporter carrying a prolactin ER targeting
Table 1 Misreading and read-through, Hurler disease, and
cystic ﬁbrosis associated read-through
Misreading Read-
through
Transfectants CGCa AGAb UGA
HEK untreated 100 100 100
Geneticin [400 µM] 562 ± 59 104 ± 21 1963 ± 126
RPS2 WT 112 ± 8 114 ± 7 109 ± 5
RPS2 A226Y 246 ± 15 111 ± 7 593 ± 35
Read-through
UAG UAG UAG
Hurler disease context Control W392X W402X
RPS2 WT 123 ± 12 156 ± 12 131 ± 31
RPS2 A226Y 420 ± 82 628 ± 35 711 ± 142
Gentamicin [500 µM] 489 ± 53 285 ± 16 307 ± 24
Paromomycin [4mM] 901 ± 138 708 ± 51 759 ± 203
UGA UGA UGA
Cystic ﬁbrosis context Control G542X W1282X
RPS2 WT 119 ± 16 109 ± 5 119 ± 7
RPS2 A226Y 419 ± 89 206 ± 16 322 ± 31
Gentamicin [500 µM] 244 ± 28 217 ± 18 173 ± 14
Paromomycin [4mM] 376 ± 64 203 ± 12 285 ± 48
Values are shown as % to HEK WT untreated. Bold text indicates values signiﬁcantly different
from the WT control (p < 0.05). Misreading agents geneticin, gentamicin, and paromomycin
used as positive controls
anear-cognate codon (His CAC→Arg CGC)
bnon-cognate codon (His CAC→Arg AGA)
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sequence and a KDEL ER retention sequence to detect differences
in ER trafﬁcking between the A226Y mutant and RPS2 wt.
Western blotting against Fluc in the total cell lysates revealed a
signiﬁcantly lower ER-localized/cytosolic Fluc ratio in A226Y
mutants when compared to controls, indicating that transport
into the ER is reduced in A226Y mutants (Fig. 2f, g, Supple-
mentary Fig. 5). In addition, we consistently found elevated
transcript levels of SGTA and RNF126, key components of the
mislocalized protein (MLP) degradation pathway32,33, suggesting
a re-routing of ER-destined proteins to the proteasome via pre-
emptive quality control pathways34.
Chronic mistranslation silences the UPR. Protein stress in the
ER is detected by three UPR sensors (PERK, IRE1, and ATF6)
which activate a transcriptional response that temporarily reduces
protein synthesis while improving the folding and clearance
capacity of the ER17. Surprisingly, we found reduced transcript
levels of key UPR signaling factors, i.e., IRE1, XBP1 – a tran-
scription factor activated by IRE1, ATF6, and ATF4, a central
transcriptional regulator downstream of the PERK signaling
pathway (Fig. 3a). Decreased expression of these UPR activation
pathways in the A226Y mutants was conﬁrmed using qRT-PCR
(Fig. 3b). In addition, XBP1 splicing, a key step in IRE1 signaling,
showed no signiﬁcant difference between A226Y and the wild-
type (Fig. 3c). Taken together, the data suggest that the UPR
sensors responsible for transcriptionally activating the UPR were
downregulated in the A226Y mutants compared to the RPS2 wt.
Next, we examined downstream UPR effectors transcription-
ally activated by PERK, IRE1, and ATF6 signaling. One hundred
and thirty-ﬁve from a total of 228 reported UPR target genes were
differentially regulated in the A226Y mutants compared to wild-
type. Interestingly, the majority of those genes belonged to one of
two categories: ER protein quality control (41/135) or translation
(39/135) (Fig. 3d). In the A226Y mutants, decreased gene
transcript levels were observed for all components of the ER
protein quality control, including ER-resident chaperones, N-
linked glycosylation-related proteins, protein disulﬁde isomerases
(PDIs), peptidyl-prolyl isomerases (PPIs), and components of the
ER-associated degradation (ERAD) pathway (Fig. 3e). To
compare our ﬁndings with an acute UPRER inducer, we treated
HEK293 cells with the aminoglycoside geneticin. Interestingly,
both UPR effector and target genes of geneticin-treated cells were
strongly upregulated, in sharp contrast to the A226Y response
(Supplementary Fig 6).
Downregulation of the UPR to avoid triggering of apoptosis.
We hypothesized that UPRER is silenced during chronic ribosomal
mistranslation in order to avoid triggering UPR-mediated
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apoptosis. Although the exact molecular mechanisms involved in
UPRER triggered apoptosis are not fully elucidated, extensive ER
stress has been reported to trigger apoptosis using one of two
pathways. The ﬁrst route is linked to transcription factor CHOP
(also named GADD153)35. CHOP is regulated by PERK activation
and activates downstream effectors like TRIB3 to trigger
mitochondria-dependent apoptosis36. Interestingly, PERK-deﬁcient
or CHOP-deﬁcient cells still undergo apoptosis during ER stress,
mediated by p53 activation of BH3-only pro-apoptotic BIK37.
Based on RNA-Seq and qRT-PCR data, transcript levels of
CHOP, TRIB3 and p53 were all signiﬁcantly downregulated in
the A226Y mutant compared to the wild-type (Fig. 3f). Western
blotting of p53 similarly showed reduced levels of p53 in the
A226Y mutants (Fig. 3g). Consistently, the A226Y mutants
showed no signiﬁcant differences in apoptosis compared to wild-
type when determined by caspase 3/7 activity and TUNEL
staining (Fig. 3h, i). On the other hand, geneticin-treated cells
which showed activation of the three arms of the UPRER have
increased levels of CHOP and readily underwent apoptosis
(Supplementary Fig. 6d, e). In further support of our hypothesis,
mutant A226Y cells show heightened susceptibility to p53-
mediated apoptosis. Thus, treatment with p53 activator RITA
induced a signiﬁcantly higher level of apoptosis in the A226Y
mutants compared to the wild-type (Fig. 3j). These results, taken
together provide evidence that the UPRER is silenced during
chronic protein mistranslation to avoid triggering apoptosis.
Linking the mitochondria to proteostasis. In sharp contrast to
limiting protein import into the ER, we found increased tran-
script levels for components of the mitochondrial import
machinery, chaperones, mitochondrial organization and protein
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synthesis (Fig. 4a, b, Supplementary Fig. 3d, 7a). We stained cells
with Mitotracker DeepRed (total mitochondrial content) and
tetramethylrhodamine ethyl ester (TMRE-mitochondrial mem-
brane potential). Increased Mitotracker DeepRed and TMRE
staining were observed by FACS in the A226Y mutant, indicative
of increased mitochondrial mass (Fig. 4c). We also estimated the
number of mitochondria by quantifying relative amounts of
mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) as
previously described38. The A226Y mutants showed a sig-
niﬁcantly higher mtDNA/nDNA ratio when compared to wild-
type (Fig. 4d).
We next examined whether the A226Y mutation affected
translation of mRNA derived from mtDNA. In contrast to
cytoplasmic translation, in vivo mitochondrial protein synthesis
was not affected by the A226Y mutation (Fig. 4e, Supplementary
Fig. 7b). Despite having more mitochondria per cell, we found
that basal respiration as determined by oxygen consumption rate
and ATP production was signiﬁcantly reduced in the A226Y
mutant suggestive of impaired mitochondrial function39 (Fig. 4f,
g). We looked for evidence of oxidative stress and found an
increase in reactive oxygen species and an upregulation of the
majority of antioxidant genes in the A226Y mutants (Fig. 4h, i).
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We also found that the A226Y mutation was associated with
enhanced mitophagy, as assessed by immunoﬂuorescence micro-
scopy quantifying the overlap of TOM20 (mitochondria) and
LAMP1 (lysosomes) staining (Fig. 4k).
While these observations are suggestive of classical mitochon-
drial dysfunction, a recent report has proposed an active role for
mitochondria during proteostasis in yeast, where cytosolic
aggregation-prone proteins become imported and degraded
within the mitochondria40. As the import of mitochondrial
proteins relies on the electrochemical potential of the inner
mitochondrial membrane, we treated cells with the mitochondrial
uncoupler CCCP, a disruptor of the inner mitochondrial
membrane potential, to study the cellular susceptibility to
pharmacological impairments of mitochondrial import41. Com-
pared to RPS2 wt cells, the A226Y mutants were signiﬁcantly
more susceptible to treatment with CCCP, as detected by cell
viability staining using Alamar Blue (Fig. 4j). To further explore
the relationship between mistranslation and mitochondrial
biogenesis observed in the A226Y mutants, we studied the
response to geneticin, a known misreading agent. We observed
similar responses in mitochondrial import, translation, biogenesis
and mitophagy as in the A226Y mutants (Supplementary
Figs. 7c–e, 8a, c). In addition, an increase in the load of misfolded
proteins at the post-ribosomal level induced by inhibition of
proteasome function, led to an increase in mitochondrial mass
and mitophagy (Supplementary Fig. 8b, c). Altogether, these
results connect mistranslation with increased mitochondrial
biogenesis and mitophagy, thus providing circumstantial evi-
dence for a mitochondrial role in proteostasis.
Mitochondrial localization of misfolded cytosolic proteins. To
examine whether mistranslated proteins associate with mito-
chondria we performed fractionation experiments of cells trans-
fected with misfolding-prone wild-type luciferase (WT-Fluc) and
a mutant aggregation-prone luciferase derivative (DM-Fluc)40.
Puriﬁcation of mitochondria and western blotting demonstrated
physical association of misfolded-prone WT-Fluc with mito-
chondria, association with the mitochondrial fraction was more
pronounced for the mutant DM-Fluc (Fig. 5a, b). Treatment with
the misreading agent geneticin resulted in increased localization
of WT-Fluc to mitochondria (Fig. 5c, d). Functional assays of
speciﬁc enzymatic luciferase activity demonstrated that the luci-
ferase protein in the mitochondrial fraction shows drastically
reduced enzymatic activity as compared to the cytosolic lucifer-
ase, indicating that the vast majority of mitochondrially localized
luciferase is misfolded and enzymatically inactive (Fig. 5e, f).
To examine the association of misfolded Fluc with mitochon-
dria we treated puriﬁed mitochondrial fractions from cells
expressing WT-Fluc with proteinase K to eliminate misfolded
Fluc attached to the outside of mitochondria (Fig. 5g). The
mitochondrial outer and inner membranes were permeabilized
using digitonin and Triton X-100, respectively42. Western blot
analysis showed that substantial amounts of Fluc stayed intact
after treatment with proteinase K alone or in combination with
digitonin permeabilizing the outer mitochondrial membrane, and
is degraded only after treatment with proteinase K in combina-
tion with Triton X-100, dissolving both outer and inner
membrane. COX1 was used as a control for a protein localized
in the mitochondrial matrix. As a further control we used WT-
Fluc with a mitochondrial targeting signal (MTS-WT-Fluc). The
mitochondrial targeting signal directs the import of the Fluc
reporter into the mitochondria. MTS-WT-Fluc in mitochondrial
fractions was protected from treatment with proteinase K alone
or in combination with digitonin and was degraded only upon a
combined treatment with proteinase K and Triton X-100
(Fig. 5h).
The results from the cell fractionation experiments indicate
that misfolded luciferase associates with and becomes imported
into mitochondria. We performed additional experiments to
visualize localization of misfolded luciferase and to substantiate
this conclusion more directly. We employed the split GFP system,
where the ﬁrst ten β-strands of GFP (GFP1–10), fused with
mCherry, are targeted to mitochondria through linkage with a
mitochondria targeting sequence (MTS-mCherry-GFP1–10), while
the eleventh β-strand (GFP11) is linked to a reporter. Mitochon-
drial GFP ﬂuorescence is expected only if the GFP11-linked
reporter enters mitochondria. As reporter we used glutathione S-
transferase (GST), as control for a stable cytosolic protein, the
misfolded-prone wild-type luciferase (WT-Fluc), the mutant
aggregation-prone DM-Fluc, and MTS-GFP11 as positive control.
Each construct was cotransfected with a plasmid expressing MTS-
mCherry-GFP1–10. For further localization of the split-GFP signal
and to exclude aberrant expression of MTS-mCherry-GFP1–10 we
used staining with TOM20, a mitochondrial protein of the outer
membrane.
The positive control, MTS-GFP11, showed a prominent
mitochondrial GFP signal, whereas the negative control, GST-
GFP11, showed no mitochondrial split-GFP signal (Fig. 6a–c).
Misfolding-prone WT-Fluc-GFP11 and mutant DM-Fluc-GFP11
showed an increasingly strong GFP signal, which colocalized with
TOM20, demonstrating that misfolding-prone and aggregation-
prone cytosolic reporter proteins associate with mitochondria
(Fig. 6d–j). We next treated HEK293 cells expressing WT-Fluc-
GFP11 or DM-Fluc-GFP11 with the misreading agent geneticin to
examine whether drug-induced mistranslation affects mitochon-
drial localization of the Fluc-GFP11 reporters. Treatment with
geneticin resulted in signiﬁcantly increased split GFP ﬂuorescence
for both WT-Fluc and DM-Fluc as assessed by ﬂuorescence
microscopy and FACS analysis (Fig. 7).
Discussion
We know surprisingly little about the cellular response to changes
in the average error rate of mRNA decoding, and how the various
individual pathways interact to maintain cell function when
ribosomal accuracy is impaired. Towards this end, we generated
what is to our knowledge, the ﬁrst ever reported mammalian ram
mutant by genetic manipulation of ribosomal protein S2. The
mutation affects general translation by increasing the random
misincorporation of near-cognate amino acids. Compared to
HEK293 cells transfected with a wild-type RPS2 gene and a
transgene expression level of 30–40% of total RPS2 mRNA,
HEK293 cells transfected with the A226Y mutant RPS2 transgene
showed a reduced expression corresponding to ~10% of total
RPS2 mRNA (Fig. 1a). While the reduced expression of the
mutant transgene likely reﬂects the ﬁtness-associated cost of
ribosomal misreading, our data demonstrate that even at this level
of expression, the mutant RPS2 protein conferred signiﬁcant
ribosomal misreading as testiﬁed by misreading and read-through
reporters (Table 1). Starting with a global transcriptomic
approach, we proﬁled and further characterized the mammalian
response towards chronic mistranslation. Chronic mistranslation
led to a proteostatic response that attenuated cytosolic protein
synthesis and the cell cycle, while increasing expression of cha-
perones and the ubiquitin-proteasome system to prevent accu-
mulation of misfolded proteins. Pointing to increased proteolytic
activity as an adaptive response towards ribosomal mistransla-
tion, we found that RPS2 A226Y mutant cells show increased
susceptibility to treatment with the proteasomal inhibitor
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MG132. Activation of proteasome-mediated proteolysis was
accompanied by increased recycling of amino acids.
Rapid attenuation of global protein synthesis under
protein stress has been largely attributed to the inhibition of
translation initiation43. Here, we found little or no evidence of
initiation inhibition. Instead, we found that in addition to
decreased transcript levels of genes involved in cytosolic protein
synthesis the reduced translational activity observed in the RPS2
A226Y mutant is associated with elongation slowdown. This
ﬁnding is supported by a recent report on the ﬁne-tuning of
ribosomal elongation in response to proteotoxic stress44.
An important contributor of the UPRER, often left unnoticed,
is the regulation of protein transport across the ER membrane.
Here, we showed that mRNA transcripts representing all three
major pathways for ER import were decreased in the mutant.
Further transcriptomic changes suggest that ER-destined proteins
are rerouted to an alternative pathway for proteolytic digestion
using the MLP quality control machinery. We used an ER-
luciferase reporter to directly demonstrate that protein import
into the ER was reduced in the A226Y mutant. We compared our
ﬁndings to a study using classical UPRER inducing agent tuni-
camycin45. Tunicamycin showed a completely opposite tran-
scriptomic response, upregulating the expression of all ER
translocation machineries (Supplementary Fig. 9). In contrast to
tunicamycin, which creates ER stress by inhibiting glycosylation
of export-bound glycoproteins within the ER, the A226Y mutants
affect the ER at a pre-ER stage, i.e., by increasing the error rate of
protein synthesis. On the basis of our observations, we hypo-
thesize that limiting ER protein translocation shields the ER from
import of mistranslated proteins, thus preventing the ER from an
overload of proteins which would trigger apoptosis through
prolonged activation of the UPRER stress sensors. In addition to
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shielding the ER by limiting protein translocation, we found
increased gene transcripts for the small GTPase Sar1 which
controls ER export and facilitates trafﬁcking of misfolded ER
proteins to the Golgi46,47.
Our data reveal an unexpected downregulation of the UPRER
pathway in the A226Y mutants. Supported by heightened sus-
ceptibility to p53-mediated cell death in the A226Y mutants, our
ﬁndings suggest that the downregulation of UPRER may aid in
circumventing UPRER triggered apoptosis. The ﬁnding that
chronic ribosomal mistranslation triggers silencing of the UPRER
was unexpected, as previous reports using classical UPR inducers
concluded that under conditions of unresolved ER stress, terminal
UPRER is activated, resulting in cell death48. How chronic mis-
translation silences UPRER to avoid triggering UPR-mediated
apoptosis remains a subject for future investigation.
In sharp contrast to limiting protein import into the ER, we
observed a signiﬁcant activation of mitochondrial import, bio-
genesis and increased mitophagy in the A226Y mutants. These
ﬁndings are mirrored by treatment with proteasome inhibitors
and aminoglycosides, known misreading agents. Thus, proteo-
toxic stress induced either by increasing ribosomal mistranslation
or by inhibiting proteasomal degradation, lead both to an increase
in mitochondrial import, biogenesis and mitophagy. The
importance of mitochondria in the cell’s response to increased
protein misfolding is supported by the heightened susceptibility
of the A226Y mutants to CCCP, a disruptor of the mitochondrial
membrane potential required for protein import.
The progressive loss of proteostasis observed during aging and
neurodegenerative diseases has been characterized by the accu-
mulation of protein aggregates and mitochondrial dysfunc-
tion49,50. In addition, aggregation-prone markers of
neurodegenerative diseases like the amyloid β-peptide have cur-
iously been found to accumulate in the mitochondria51,52. Thus
far, it remained unclear how mitochondrial dysfunction and
protein aggregation could be related. It was recently shown in
yeast that aggregation of cytosolically misfolded proteins occurs
in a partly organelle-based manner, facilitating asymmetric
retention upon cell division and import into the mitochondria for
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of split-GFP signal by FACS. Normalized split-GFP/mCherry ratio relative to Fluc expression (median ﬂuorescence ± SEM; N≥ 6). **p < 0.01, ***p < 0.005.
N= number of independent transient transfections for each vector; for each transfection 3 technical replicates were done
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degradation40,53. The import of protein aggregates was dependent
on the mitochondrial import machinery and on yeast-only cha-
perone Hsp104, possibly to assist the unfolding of protein
aggregates to enable entry via the Tom40 channel complex.
Using cell fractionation experiments and treatment with pro-
teinase K with or without membrane-permeabilizing detergents
in combination with functional enzymatic activity assays and
visualization by means of the split GFP system, we directly
demonstrate that cytosolically misfolded proteins localize to
mitochondria in HEK293 cells, thus providing strong evidence for
a role of mitochondria in proteostasis in mammalians. We
hypothesize that aggregation-prone proteins enter the mito-
chondria for compartmentalization and subsequent degradation.
Chronically, accumulation of misfolded proteins in the mito-
chondria may lead to mitochondrial dysfunction, as observed in
the A226Y mutants. In addition, the slowdown of protein import
into the ER as observed in the mistranslating A226Y mutants may
promote mistargeting of proteins normally targeted to ER to the
mitochondria54,55. While the mechanistic details require further
investigation, we hypothesize that the increase in mitophagy of
the A226Y mutants functions to selectively degrade dysfunctional
mitochondria together with their proteostatic “load”. This offers
an attractive pathomechanistic concept for loss-of-autophagy
associated neurodegeneration in mice56,57 and for familial Par-
kinson’s disease58,59 associated with mutations in parkin, a ubi-
quitin ligase promoting mitophagy.
Our approach using global gene expression proﬁling to study
the cellular response towards chronic ribosomal mistranslation
has enabled us to characterize how various individual pathways
work together and to uncover previously undescribed responses.
Our data provide a framework for further elucidation of networks
that contribute to protein homeostasis.
Methods
Vector construction and generation of stable transfectants. Expression vectors
pRPS2-WT and pRPS2-A226Y were constructed by Genoway, France. Using 5′-
BamHI and 3′-AvrII restriction sites, the mouse Rps2 coding sequence [WT/A226Y
(GCC→TAC)] was ligated into a proprietary eukaryotic expression vector which in
addition to the CAGGS promoter carries the human growth hormone poly-
adenylation signal. The amino acid sequences of mouse and human Rps2 are
identical. The mouse gene was chosen, because the difference in nucleic acid
sequences between human and mouse RPS2 allows for precise quantiﬁcation of
transfected mouse RPS2 mRNA and endogenous human RPS2 mRNA. For
visualization of target gene expression RPS2 was linked to IRES-eGFP. In addition,
a HygR cassette from plasmid pGL4.14 (Promega) was inserted at the MluI
restriction site. HEK293 cells were transfected with pRPS2 (WT/A226Y) expression
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Fig. 7 Mistranslation increases the proportion of misfolded Fluc associated with mitochondria. HEK293 cells cotransfected with FlucWT-HA-GFP11/MTS-
mCherry-GFP1–10 and FlucDM-HA-GFP11/MTS-mCherry-GFP1–10 were treated with the misreading agent geneticin–images are arranged as in Fig. 6.
a, b Representative images of cells transfected with FlucWT-HA-GFP11 and treated with 800 µM geneticin for 24 h. Panels are arranged as in Fig. 6a–g. Cell
expressing MTS-mCherry-GFP1–10 is marked by a single white triangle, cell co-expressing both FlucWT-HA-GFP11 and MTS-mCherry-GFP1–10 is marked by
two white triangles. c Quantiﬁcation of normalized GFP/mCherry ratio as assessed by wide-ﬁeld ﬂuorescence microscopy, median ﬂuorescence ± SEM
(N≥ 3). d Treatment with 400 µM and 800 µM increases association of Fluc with mitochondria in a dose-dependent manner; quantiﬁcation of normalized
split-GFP/mCherry ratio relative to Fluc expression by FACS (median ﬂuorescence ± SEM; N= 6). *p < 0.05, **p < 0.01, ***p < 0.005. N= number of
independent transient transfections for each vector; for each transfection 3 technical replicates were done
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vectors using Turbofect (Thermo Fisher Scientiﬁc) and cultured in DMEM with
10% FBS under 100 µg/ml hygromycin B selection for 5–7 weeks. GFP expressing
colonies were picked for further characterization. GFP ﬂuorescence was analyzed
by ﬂow cytometry using the BD FACS Canto II (BD Biosciences) and the FlowJo
software (Tree Star Inc). Several independent clones from each pRps2-WT and
pRps2-A226Y transfected cells were used for all further experiments; the number of
independent clones used in each experiment is speciﬁed in the corresponding
ﬁgure legend.
Plasmids MTS-mCherry-GFP1–10, FlucWT-HA-GFP11, and FlucDM-HA-
GFP11 were obtained from Addgene, USA40. NeoR cassette in vectors FlucWT-
HA-GFP11 and FlucDM-HA-GFP11 was replaced with AmpR and HygR cassettes
from vector pGL4.14 (Promega) using 5′-Stul and 3′-Pcil restriction sites resulting
in vectors FlucWT-HA-GFP11-hyg and FlucDM-HA-GFP11-hyg.
Determination of RPS2 mRNA expression. mRNA was isolated using TRIzol
(Thermo Fischer). qRT-PCR was used to determine the relative ratio of RPS2
transgene mRNA to endogenous RPS2 mRNA using RPS2 primers ﬂanking the site
of mutation. Discrimination was achieved using TaqMan probes speciﬁc for
human wild-type endogenous RPS2 (5′-CAC CTC AGC CCG GG-3′, VIC), wild-
type mouse transgene (5′-TGC TAC ACT TCA GCC-3′, NED) or mutant mouse
transgene (5′-CTA CAC TTC ATA CAG AG-3′ for A226Y, FAM). Experiments
were conducted in triplicates using the TaqMan Kit (Life Technologies) and the
ABI 7500 Fast Real-Time PCR System (Life Technologies). Ampliﬁcation of 40
cycles (95 °C for 20 s and 60 °C for 45 s); the ratio of transgene versus endogenous
RPS2 was calculated as previously described60.
Detection of transfected RPS2 in polysome fractions. For cellular localization of
the transgenic RPS2 protein, a myc-tag (EQKLISEEDLN) was introduced to the C-
terminal of RPS2, and western blotting using anti-myc antibodies was performed.
For preparation of S100 and ribosome fractions the cell lysate prepared as in61
was diluted to 2 ml and adjusted to 0.5 M KCI. Cell lysates were loaded on a 1M
sucrose cushion in 3-ml polycarbonate tubes and ultracentrifuged for 2 h at
250,000 × g at 4 °C in a TL100.3 rotor (Beckman). The supernatant above the
sucrose cushion was collected (S100 fraction). The pellet (ribosome fraction) was
re-suspended in buffer (20 mM Hepes pH= 7.6, 100 mM KCI, 5 mM MgCI2, 1×
protease inhibitor cocktail, EDTA free).
Polysome proﬁling was performed as previously described in ref. 61. Five OD260
units were loaded onto a 5–50% sucrose gradient, ultracentifuged (SW41 rotor,
36,000 rpm, 4 °C) for 2 h, and fractionated using a Teledyne ISCO Polysome
Proﬁler System. Fractions were collected and analyzed by western blot.
Western blot and antibodies. Cells were grown to 70% conﬂuency in DMEM
with 10% FBS, lysed with 1× Passive Lysis Buffer (Promega) and ultrasonicated.
Lysates were centrifuged (15,000 × g, 10 min), supernatant harvested and normal-
ized to protein concentration as measured using Micro BCA Protein Assay Kit
(Thermo Scientiﬁc). The speciﬁc antibodies used in this study were: polyclonal
anti-myc (Abcam, ab9106); polyclonal anti-RPS2 (Abcam, ab154972); polyclonal
anti-RPS9 (Abcam, ab117861); polyclonal anti-tubulin (Abcam, ab6046); poly-
clonal anti-alpha actin (Abcam, ab5694); polyclonal anti-peIF2α (Cell Signaling,
9721S); anti-eIF2α (Cell Signaling, 9722); polyclonal anti-ubiquitin (Abcam,
ab7780); polyclonal anti-GAPDH (Abcam, ab9485); mouse monoclonal anti-p53
(Abcam, ab26); HRP-conjugated goat anti-rabbit (Invitrogen, G-21234); and goat
anti-mouse antibodies (Invitrogen, A10551).
Dual luciferase mistranslation reporter assay. Mistranslation was assessed as
described previously23,24. Brieﬂy, misreading was determined using the pRM
hRluc-hFluc H245R vector, where His245 (CAC codon) was replaced by Arg245
(near-cognate CGC codon or non-cognate AGA codon). Read-through was
determined using pRM hRluc-hFluc D357X, where Asp357 (GAC codon) was
replaced by a UGA nonsense-codon in the ﬁreﬂy luciferase (Fluc) transcript. Cells
were transfected using TurboFect (Thermo Fischer) according to manufacturer’s
protocol. After 24 h incubation, cells were lysed and luminescence measured using
the FLx800 luminometer (Bio-Tek Instruments). Renilla luciferase (rluc) activity
was used as an internal control. Misreading and read-through were calculated by
the ratio mutant Fluc/Rluc activity to wild-type Fluc/Rluc activity. For drug
treatments, cells were transfected, incubated overnight, then treated with the drug
for further 24 h prior to lysis and measurement of luciferase activity.
For the measurement of Hurler/CF-associated read-through, vector pRM
hRluc-TGA-hFluc, which contains hRluc and hFluc separated by 27nt linker
encoding for polypeptide STCDQPFGF with glutamine (Q) replaced by a UGA
nonsense codon23 was modiﬁed as follows. Restriction sites EcoRI and XhoI were
introduced to the 5′-end and 3′-end ﬂanking the Rluc-Fluc linker sequence,
resulting in vector pRM-hRluc-TGA2-hFluc. Vectors required for Hurler/CF-
associated read-through were constructed by exchanging the linker sequence via
the introduced EcoRI and XhoI restriction sites. Each linker included ﬁve allele-
speciﬁc codons up-and downstream of the stop codon and restriction sites 5′-XhoI
and 3′-EcoRI. TAG vector linker, 5′-TCGAG/TCG ACG TGC GAT TAG CCG
TTC GGA TTC G/AATT-3′; Hurler disease context W392X linker62, 5′-TCGAG/
GAT GGA GAA CAA CTC TAG GCA GAG GTC TCA AAG G/AATT-3′; Hurler
disease context W402X linker63, 5′-TCGAG/GAT GAG GAG CAG CTC TAG
GCC GAA GTG TCG CAG G/AATT-3′; Cystic ﬁbrosis G542X linker64, 5′-
TCGAG/GAC AAT ATA GTT CTT TGA GAA GGT GGA ATC ACA G/AATT-
3′; Cystic ﬁbrosis W1282X linker65, 5′-TCGAG/ATA ACT TTG CAA CAG TGA
AGG AAA GCC TTT GGA G/AATT-3′. Subcloning of the inserts into pRM-
hRluc-TGA2-hFluc backbone using XhoI and EcoRI restriction sites produced
vectors pRM-hRluc-Hu-W392X-hFluc, pRM-hRluc-Hu-W402X-hFluc, pRM-
hRluc-CF-G542X-hFluc, pRM-hRluc-CF-W1282X-hFluc, and pRM-hRluc-TAG-
hFluc.
Generation time assay. Cell growth was monitored using Alamar blue (Life
Technologies). HEK293 cells were seeded on 24-well plates (BD Falcon) at low
density and incubated in DMEM with 10% FBS at 37 °C. 10% Alamar blue (v/v)
was added at time points 0, 24, 48, and 72 h and ﬂuorescence was measured
(excitation: 530 nm, emission: 590 nm) after 3 h incubation. Signal intensities at
time point 0 h were set as one and growth curves were plotted. Generation time was
calculated as tD= ln(2)/slope.
Fireﬂy luciferase protein aggregation assay. pRM-hFluc was constructed by
replacing hRluc in vector pGL4.75 (Promega) with Fluc from vector pGL4.14
(Promega). Cells were transiently transfected with pRM-hFluc. Forty-eight hours
post transfection cells were resuspended in 1× Passive Lysis Buffer (Promega) at a
1:5 ratio for cell lysis and fractionated by centrifugation (16,000 × g for 25 min) into
soluble and pellet fractions. The resulting fractions were analyzed by western blot
using HRP-conjugated speciﬁc anti-Fluc antibodies (Abcam). The signal intensity
of the Fluc bands in the different fractions was quantiﬁed using ImageQuant (GE
Healthcare) and the ratio between pellet and soluble fractions was calculated.
ER-ﬁreﬂy luciferase protein trafﬁcking assay. Cells were transiently transfected
with the ER-luciferase reporter vector pRM-PLN-hFluc-KDEL, carrying unmodi-
ﬁed ﬁreﬂy (Fluc) luciferase with an N-terminal prolactine signal sequence for ER
transport (MNIKGSPWKGSLLLLLVSNLLLCQSVAP) and a C-terminal KDEL
retention sequence. Forty-eight hours post transfection cells were resuspended in
MTE-P buffer (270 mM D-mannitol, 10 mM Tris base, 0.1 mM EDTA, pH= 7.4,
supplemented with 1 mM PMSF) and homogenized using a Dounce homogenizer.
Homogenates were centrifuged at 1400 × g for 10 min at 4 °C to remove cellular
debris. An aliquot of supernatant was kept as total cellular protein fraction and the
remaining supernatant was centrifuged at 15,000 × g for 10 min at 4 °C. The
supernatant was loaded on a sterile 14 × 89–mm polyallomer ultracentrifuge tube
(Beckman) containing a sucrose gradient (3 ml 1.3 M sucrose, 3 ml 1.5 M sucrose,
2 ml 2.0 M sucrose; 10 mM Tris base, 0.1 mM EDTA, pH= 7.6) and centrifuged at
152,000 × g for 70 min at 4 °C, acceleration/deceleration= 1. Using a 20-G needle
and 1 ml syringe, the interface containing the ER was collected. The ER fraction
was transferred to a 5.0 ml, 13 × 51 mm polyallomer ultracentrifuge tube (Beck-
man) and supplemented with additional ice-cold MTE-P to a ﬁnal volume of 4 ml.
Tubes were covered with paraﬁlm and mixed by inversion until the suspension was
homogeneous and ultracentrifuged at 126,000 × g for 45 min at 4 °C (36700 rpm,
SW60Ti rotor). Supernatant was discarded and the pellet was resuspended in ice-
cold MTE-P. The resulting fractions were analyzed by western blot using HRP-
conjugated speciﬁc anti-Fluc antibodies (Abcam). The signal intensity of the Fluc
bands in the different fractions was quantiﬁed using ImageQuant (GE Healthcare).
Endo H treatment. Endo H glycosidase (Promega) treatment was done according
to manufacturer’s protocol. Sixty microliter of total cellular protein extract were
denatured at 95 °C for 5 min using denaturating solution, cooled down to room-
temperature for 5 min, Endo H buffer (Promega) and 2000 units of Endo H gly-
cosidase were added. Samples were incubated for 3 h at 37 °C. The resulting
samples were analyzed by western blot using HRP-conjugated speciﬁc anti-Fluc
antibodies (Abcam). The signal intensities of the Fluc bands were quantiﬁed using
ImageQuant.
In vivo cytoplasmic translation. HEK293 cells were grown in 24-well plates in
DMEM with 10% FBS to 80% conﬂuency, washed and incubated for 30 min in
methionine-free RPMI. The media was replaced with methionine-free RPMI
supplemented with 10 mCi of 35S-Methionine (Hartmann) and incubated at 37 °C
for the indicated time periods. Translation was stopped by the addition of a stop
medium (DMEM supplemented with 100 µg/ml cycloheximide and 1 mg/ml cold
methionine). Cells were detached by pipetting and washed once with 1× PBS before
lysing with 1× Passive Lysis Buffer (Promega). Proteins were precipitated with 10%
TCA (Sigma). Precipitates were collected on GF/C ﬁlter membranes (Perkin-
Elmer) and [35S] incorporation was measured by scintillation counting (Perkin
Elmer Trilux MicroBeta 96-well format counter).
Polysome extraction, proﬁling, and runoff assays. Polysome extractions were
performed as previously described61. One OD260 unit was loaded onto a 8–50%
sucrose gradient, ultra-centrifuged (SW41 rotor, 39,000 rpm, 4 °C) for 3 h, and
analyzed using a Teledyne ISCO Polysome Proﬁler System. For the polysome
runoff assay, cells were grown in 15 cm petri dishes to 80–90% conﬂuency. The
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cells were detached using Accutase and resuspended in DMEM with 10% FBS. The
cell suspension was incubated in a shaking incubator at 37 °C, 100 rpm for 1 h. At
the start of the experiment, cells were pretreated with 1 µg/ml Harringtonine
(Enzo) for different time points (t= 0 min, 2.5 min, and 5 min) and 100 µg/ml
cycloheximide was added at the end point. The cells were kept on ice until
they were pelleted at 500 × g for 5 min. Polysomes were analyzed as described
above. Relative polysome/monosome (P/M) ratios were calculated and normalized
to t= 0.
Cell cycle analysis using propidium iodide staining. DNA staining with propi-
dium iodide (Thermo Scientiﬁc) was used to allow distinction between G1, S,
and G2/M phase cells. At ~80% conﬂuency, cells seeded in 12-well plates were
washed with PBS and trypsinized. The detached cells were resuspended in DMEM
and centrifuged for 5 min at 500 × g at room temperature. The pellets were
resuspended in 300 μl ice cold PBS. One mililiter of ice cold 70% ethanol was added
to detached cells and incubated for at least 2 h at −20 °C for ﬁxation. Next, cells
were permeabilized by adding 350 μl of 0.05% Triton X-100 diluted in PBS (PBSX).
After washing twice with PBS, cells were stained using 300 μl of staining solution
(50 μg/ml propidium iodide, 20 μg/ml RNase A in PBS) for 30 min in the dark.
Fixed and stained cells were analyzed by ﬂow cytometry using the BD FACS Canto
II (BD Biosciences) and the FlowJo data analysis software (Tree Star Inc).
Cell cycle ELISA. Levels of cell cycle marker protein CDK2 protein phosphorylated
TYR15 (CDK2-pTYR15) were determined using the Abcam Cell Cycle In-Cell
ELISA Kit (ab140363) and performed according to manufacturer instructions.
Proteasome activity. Proteasome activity was determined as previously descri-
bed66. Brieﬂy, cells were grown to 80% conﬂuency and lysed using Passive Lysis
Buffer (Promega). After centrifugation (16,000 × g, 10 min, 4 °C), protein con-
centration of the supernatant was determined using the Micro BCA Protein Assay
Kit (Thermo Fischer). Activity assays were performed with 50 μg of total protein
(200 μl total) in 96-well plates by adding 100 μM Suc-Leu-Leu-Val-Tyr-AMC
peptide substrate (chemotrypsin-like activity; Bachem, I-1395) or 100 μM
Ac–NIe–Pro–NIe–Asp–AMC (caspase-like activity; Bachem, I-1850). Fluorescence
(excitation 380 nm, emission 460 nm) was measured every 5 min for 1 h at 25 °C
using a microplate ﬂuorometer Synergy H1 (BioTek).
Analysis of UPR effectors by qPCR and XBP1-splicing assay. RNA from
HEK293 cells was extracted using the ReliaPrep™ RNA Cell Miniprep Kit (Pro-
mega) and reverse transcribed using the High Capacity RNA-to-cDNA Kit
(Applied Biosystems) according to manufacturer instructions. The 5× EvaGreen®
QPCR Mix (Bio&Sell) was used together with the 7500 Fast Real-Time PCR System
(Applied Biosystems). Primers used, ATF4: forward 5′-ACC TTC GAA TTA AGC
ACA TTC CTC-3′, reverse 5′-GCC ACC TCC AGG TAA TCA TCT AAG-3′;
ATF6: forward 5′-TTG GAA GCA GCA AAT GAG AC-3′, reverse 5′-GGA GAA
AGT GGC TGA GGT TC-3′; XBP1: forward 5′-GGT CTG CTG AGT CCG CAG
CAG G-3′, reverse 5′-GGG CTT GGT ATA TAT GTG G-3′; GRP94: forward 5′-
TGG GAA GAG GTT CCA GAA TG-3′, reverse 5′-GTT GCC AGA CCA TCC
GTA CT-3′; p53:forward 5′-GCG TGT GGA GTA TTT GGA TG-3′, reverse 5′-
TGG TAC AGT CAG AGC CAA CC-3. GAPDH: forward 5′-ACC CAC TCC TCC
ACC TTT GA-3′, reverse 5′-CTG TTG CTG TAG CCA AAT TCG T-3′. GAPDH
expression was used as internal reference. Measured quantiﬁcation cycles were
analyzed according to Pfafﬂ67.
The XBP1-splicing assay was performed as previously described23.
Caspase 3/7-assays and TUNEL-assays. Caspase 3/7 activity was measured
using the ApoLive-Glo™ Multiplex Assay according to manufacturer instructions.
The in situ BrdU-Red DNA Fragmentation (TUNEL) assay kit (Abcam, ab66110)
was used to detect DNA fragmentation by ﬂow cytometry and was performed
according to manufacturer instructions. Drug-treatments (STA, 10 µM, 6 h; RITA,
1 µM, 12 h) for speciﬁc experiments were performed prior to paraformaldehyde
ﬁxing.
Mitochondria staining, mtDNA:nDNA ratio determination. To estimate mito-
chondrial mass, Mitotracker™ DeepRed FM (M22426, Invitrogen) and TMRE
(ab113852, Abcam) staining were performed according to manufacturer instruc-
tions and analyzed by ﬂow cytometry using the BD FACS Canto II and the FlowJo
software.
mtDNA:nDNA ratio was determined as previously described38. In brief, total
DNA was extracted from cells with QIAamp DNA Mini Kit (Qiagen). For mtDNA,
a fragment of the MT-TL1 gene was ampliﬁed with forward primer, 5‘-CAC CCA
AGA ACA GGG TTT GT-3‘ and reverse primer, 5‘-TGG CCA TGG GTA TGT
TGT TA-3‘. For nDNA, a fragment of the B2M gene was ampliﬁed with forward
primer, 5‘-TGC TGT CTC CAT GTT TGA TGT ATC T-3‘ and reverse primer, 5‘-
TCT CTG CTC CCC ACC TCT AAG T-3‘. Ampliﬁcation was performed in an
ABI 7500 real-time PCR system (Life Technologies) for 40 cycles (95 °C for 20 s, 62
°C for 30 s).
Basal cellular respiration. Mitochondrial respiration was measured using the
Seahorse Bioscience XF24 analyser and XF24 microplates (Seahorse Bioscience)
coated with 50 mg/ml poly-D-Lysine. ~105 cells were seeded per well in 100 µl
DMEM medium supplemented with 10% FBS, incubated for 3 h at 37 °C and 5%
CO2 for cell attachment. Next, DMEM was aspirated and replaced with serum-free
DMEM for overnight incubation. Prior to the experiment, the plate was incubated
for 30 min at 37 °C in a CO2-free incubator. Cells were subsequently washed with
Mitochondrial Assay Solution (MAS; 70 mM sucrose, 220 mM mannitol, 10 mM
KH2PO, 4.5 mM MgCl2, 2 mM HEPES, 1 mM EGTA, 0.2% (w/v) fatty acid-free
BSA, pH 7.2 at 37 °C) according to manufacturer instructions (Seahorse
Bioscience). Measurements were performed in MAS, supplemented with 10 mM
pyruvate, 10 mM succinate, 2 mM malate, and 0.2 nM Plasma Membrane Per-
meabilizer (PMP) reagent (Seahorse Bioscience). The oxygen consumption rate
(OCR) in a coupled state (state 2, basal respiration) was measured. Data was
extracted from the Seahorse XF-24 software and the bioenergetic parameters were
calculated according to the manufacturer instructions.
ATP and ROS measurements. ATP levels in HEK293 cell lines were determined
using the ViaLightTM plus kit (Lonza), which is based on luciferase activity. Five
microliter Alamar blue (Life Technologies) were added to each well and incubated
for 3 h. Alamar blue was used as an internal standard, followed by measurement of
ATP content as per manufacturer instructions.
To detect mitochondria-speciﬁc superoxide in HEK293 cell lines, MitoSOX™
Red staining (Life Technologies) was performed in live cells. Cells were grown to
~80% conﬂuency and stained with MitoSOX™ Red (5 μM) in FACS buffer (1× PBS,
2% FBS) for 30 min at 37 °C. Cells were detached using Accutase and resuspended
in FACS buffer. Fluorescence was analyzed by ﬂow cytometry using the BD FACS
Canto II and the FlowJo data analysis software.
In-vivo and in-organello mitochondrial translation. HEK293 cells were grown in
DMEM plus 10% FBS in 24-well plates to 80% conﬂuency. Cells were pre-
incubated with methionine-free RPMI supplemented with 10% dialyzed FBS for
30 min, followed by 100 µg/ml Emetin for 10 min before the start of the experi-
ment. 100 µg/ml Emetin was supplemented in all working media to suppress
cytoplasmic translation. Cells were labeled by the addition of 20 mCi [35S]
methionine (Hartmann) and incubated to the desired time points. Translation was
stopped by the addition of 1 mg/ml cold methionine. Cells were detached by
pipetting and washed once with 1× PBS before lysing with 1× Passive Lysis Buffer
(Promega) supplemented with 0.1% SDS and 100 µU/µl DNaseI, incubated at 37 °C
for 15 min followed by 10% TCA (Sigma) precipitation. The TCA precipitated cell
extracts were collected on GF/C ﬁlter membranes (Perkin-Elmer) and [35S]
incorporation was measured by scintillation counting (Perkin Elmer Trilux
MicroBeta 96-well format counter).
Mitochondrial in-organello translation was done as previously described with
slight modiﬁcations68. The mitochondria-enriched pellet was resuspended in 1 ml
of mitochondria reaction buffer (MR-buffer) containing 15 μl of 35S-Methionine,
20 mM Tris-HCl (pH 7.2), 90 mM KCl, 4 mM MgSO4, 1.5 mM KH2PO4, 20 mM
glutamate, 0.5 mM malate, 14 mM sucrose, 44 mM sorbitol, 4 mM ADP, 0.1 mM
amino acids (without methionine), 1 mg/ml BSA (fatty acids free), and 0.1 mg/ml
cycloheximide. In-organello translation was conducted by incubating at 30 °C for
2 h on a shaker (800 rpm). Cold methionine was subsequently added to a ﬁnal
concentration of 0.1 mM, reaction mixtures were centrifuged for 5 min at 15,000 ×
g, and supernatants were discarded. The pellets were washed with cold washing
buffer containing 10 mM Tris-HCl (pH 7.4), 320 mM sucrose, 1 mM EDTA,
centrifuged for 5 min at 15,000 × g, and resuspended in 20 μl of 1× SDS loading
buffer. The samples were analyzed on 15% SDS PAGE. The gel was ﬁxed, dried and
exposed on phosphor-imager screen and scanned with laser scanner FLA-5100
(FUJI).
Detection of mitophagy. To visually assess mitophagy, cells seeded on coverslips
were ﬁxed with 4% paraformaldehyde in PBS, and immunostained with anti-
LAMP1 mouse monoclonal antibody (ab25630, Abcam) and anti-Tom20 rabbit
polyclonal antibody (sc-11415, Santa Cruz Biotech). Goat anti mouse IgG Alexa-
Flour555 (ab150118, Abcam) and goat anti-rabbit IgG Cy5 (ab97077, Abcam) were
used as secondary antibodies. Morphology and colocalization of mitochondria with
lysosomes were assessed using a CLSM Leica SP5 Confocal Laser Scanning Inverted
Microscope (Leica Microsystems) equipped with a helium neon laser. The objective
used was oil immersion ×63/1.4. Plan Apo.
Colocalization of LAMP1 and TOM20 was quantiﬁed using Mander’s
colocalization coefﬁcient on ImageJ (COLOC2 plugin).
Isolation of mitochondria for western blotting. Cells HEK293 were transiently
transfected with the luciferase reporter vectors FlucWT-HA-GFP11 or FlucDM-
HA-GFP11. Forty-eight hours post transfection cells were resuspended in MTE-P
buffer (270 mM D-mannitol, 10 mM Tris base, 0.1 mM EDTA, pH= 7.4, supple-
mented with 1 mM PMSF) and homogenized using a Dounce homogenizer.
Homogenates were centrifuged at 1400×g for 10 min at 4 °C to remove cellular
debris. An aliquot of supernatant was kept as total cellular protein fraction. The
remaining supernatant was centrifuged at 15,000×g for 10 min at 4 °C. The
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resulting supernatant was kept as cytosolic fraction. The resulting pellet was
carefully washed twice with 0.5 ml of ice-cold MTE-P, resuspended in 0.8 ml of ice-
cold MTE-P buffer and loaded slowly on top of a sucrose gradient (1 ml of 1.7 M
sucrose overlaid with 1.6 ml of 1.0 M sucrose in a sterile 5.0 ml, 13 × 51 mm
Beckman polyallomer ultracentrifuge tube). The tube was ﬁlled up with an addi-
tional 0.8 ml of ice-cold MTE-P buffer and centrifuged for 22 min at 40,000 × g,
4 °C (20600 rpm in an SW50.1 rotor). The interface between the 1.7 M and 1.0 M
sucrose layers was collected (0.4 ml) and used as source of puriﬁed mitochondria.
The mitochondria fraction was mixed with 1.1 ml of ice-cold MTE-P buffer and
centrifuged for 10 min at 15,000×g, 4 °C. Pellet was resuspended in 100 μl of MTE
buffer without PMSF and analyzed by western blotting as described.
Proteinase K treatment and mitochondrial membrane permeabilization. Vec-
tor pRM-MTS-hFluc was constructed by PCR ampliﬁcation of the MTS (Mito-
chondria Target Signal) fragment from the MTS-mCherry-GFP1–10 vector and
subsequent subcloning into the pRM-hFluc vector. HEK293 cells were transiently
transfected with pRM-hFluc or pRM-MTS-hFluc, 24 h post transfection mito-
chondrial fractions were prepared as described above and OD at 600 nm was
measured. Mitochondrial fractions were adjusted to OD600= 1.0–1.5 and 10 µl
volumes were used per reaction.
Mitochondria were permeabilized with digitonin (0.05%) or Triton-X100 (2%).
After 10 min incubation at 4 °C, proteinase K was added (200 µg/ml ﬁnal
concentration) and incubated for 2 h at 4 °C. Input control samples were kept with
cold MTE buffer w/o detergents or proteinase K. Finally, 10 µg of insulin (I5500
Sigma) were added for protein co-precipitation, followed by TCA precipitation for
30 min at 4 °C (ﬁnal concentration −20% of TCA). Following TCA precipitation
samples were centrifuged at 21,000×g for 20 min at 4 °C, and the resulting pellets
were dissolved in 30 µl of 1 M Tris-HCl pH= 7.5. Samples were analyzed by
western blotting. Anti-Fluc antibody was used to visualize luciferase protein; anti-
matrix COX1 antibody was used to control for mitochondrial integrity and loading.
Split-GFP assay. For split-GFP assay HEK293 cells were transiently co-transfected
with vectors MTS-mCherry-GFP1–10 and FlucWT-HA-GFP11-hyg or MTS-
mCherry-GFP1-10 and FlucDM-HA-GFP11-hyg. Twenty-four and 48 h post
transfection GFP and mCherry ﬂuorescence intensities were assessed by ﬂow
cytometry using FACS LSR Fortessa (BD Biosciences) or by wide-ﬁeld ﬂuorescent
microscopy using InCellAnalyser 2500HS (GE Life Sciences). For quantiﬁcation of
the FACS data, FlowJo analysis software was used. Expression levels of Fluc WT
and Fluc DM were normalized by western blot (Fluc WT versus Fluc DM) or by
luciferase activity (untreated versus geneticin treatment). GFP/mCherry ratio
relative to Fluc expression level was calculated and used as a measure of Fluc
mistargeted to mitochondria.
Quantiﬁcation of wide-ﬁeld ﬂuorescent microscopy data. Paraformaldehyde
ﬁxed cells on 12 mm cover slips were imaged on GE InCell Analyser 2500 DS
spinning disc microscope using DAPI, AlexaFluor 488 (for GFP) and RFP (for
mCherry) channels. For each sample 100 images were acquired covering in total
around 2 × 104 cells. After global threshold segmentation, cellular outlines were
acquired and integrated intensities of GFP and mCherry inside individual cells
were calculated (using CellProﬁler 3.0 software)69. Further analysis was done in
Microsoft Excel software: cell measurements were imported as individual data
rows; manual threshold was applied for the ﬁltering out extremely autoﬂuorescent
apoptotic cells and the background signal from untreated cells was subtracted. The
results were presented as the ratio between integrated intensities of GFP and
mCherry relative to luciferase activity. Each sample was independently reproduced
and analyzed 3 times.
Statistics and reproducibility. Several independent clones of each pRps2-WT and
pRps2-A226Y transfected cells were used for the experiments; the number of
independent clones used in each experiment is speciﬁed in the corresponding
ﬁgure legend. Statistical analysis was performed with Prism 5.0 software. For all
assays, except quantiﬁcation of wide-ﬁeld ﬂuorescent microscopy, unpaired Stu-
dent’s t-test was used to determine signiﬁcant difference between analyzed samples.
Signiﬁcance of wide-ﬁeld ﬂuorescent microscopy quantiﬁcation was calculated
using Mann-Whitney test.
RNA sequencing. For transcriptome analysis we used 4 independent clones of
RPS2-WT transfected cells and 3 independent clones of RPS2-A226Y-transfected
cells. RNA sequencing (RNAseq) was performed at the UZH/ETH Functional
Genomics Center Zurich (FGCZ [http://www.fgcz.ch/]) according to the Illumina
RNA sequencing protocol. Differential gene expression analysis between sample
groups of interest was performed using the R/bioconductor package edgeR70 To
analyze enrichment of genes in speciﬁc cellular functions, differential expressed
genes were mapped to process networks using MetaCore (GeneGo, Thomson
Reuters) and to known biological ontologies based on the GO project (http://www.
geneontology.org/) using gene annotation tool Enrichr71. GO terms with adjusted
p-value < 0.05 were subjected to REVIGO web page72 for removal of redundant GO
terms from the results. For the transcriptome analysis of A226Y-induced mis-
translation, three RPS2 A226Y and four RPS2 wild-type biological replicates were
compared. For the analysis of aminoglycoside induced mistranslation, cells were
treated with 16 µM geneticin in F10 medium supplemented with 15 µg/ml saponin
for 32 h; four biological replicates were used.
Metabolome analysis. For metabolome analysis we used 4 independent clones of
RPS2-WT transfected cells and 4 independent clones of RPS2-A226Y-transfected
cells. Clones were synchronized in DMEM without FBS for 24 h. Next, cells were
incubated for 24 h in DMEM containing 10% FBS. Cells were detached using
Accutase and washed three times in PBS. The dry cell pellets were snap frozen
using liquid nitrogen and stored at −80 °C. Metabolome analysis was performed by
Metabolon according to published methods73. Samples were prepared using pro-
prietary organic and aqueous extractions in order to remove proteins and to
recover maximal amounts of small molecules. The extracted samples were split in 5
parts-two for analysis by two separate reverse phase (RP)/UPLC-MS/MS methods
with positive ion mode electrospray ionization (ESI), one for analysis by RP/UPLC-
MS/MS with negative ion mode ESI, one for analysis by HILIC/UPLC-MS/MS with
negative ion mode ESI, and one sample was reserved for backup. Metabolome data
sets were analyzed by Between Group Analysis (BGA)74 using the made4 package
(bioconductor.org) in R. Normalized MS intensity data were used for BGA analyses
based on principal component analysis (PCA). BGA was applied to a data set
consisting of 578 metabolites. Results of the BGA were visualized by a scatter plot
for the ﬁrst axis of the BGA.
3D modeling. Visualization using PyMol v.1.8 (Schrödinger, Inc.) based on pub-
lished ribosome structures. Sources: S. cerevisiae ribosome PDB 4V7R; human
cytosolic ribosome PDB 4V6X.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Transcriptomic data have been deposited in NCBI’s Gene Expression Omnibus and are
accessible through GEO Series accession number GSE115153. Metabolomic data have
been deposited in EMBL-EBI MetaboLights database and are accessible through
accession number MTBLS106.
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